A carregar...
Infection risk of dermatologic therapeutics during the COVID‐19 pandemic: an evidence‐based recalibration
Recommendations were made recently to limit or stop the use of oral and systemic immunotherapies for skin diseases due to potential risks to the patients during the current severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) COVID‐19 pandemic. Herein, we attempt to identify potentially safe...
Na minha lista:
| Publicado no: | Int J Dermatol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7361427/ https://ncbi.nlm.nih.gov/pubmed/32621284 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijd.15028 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|